BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14717654)

  • 1. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
    Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
    Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus.
    Mi QS; Zhou L; Grattan M; Wang ZZ; Sivilotti M; She JX; Delovitch TL
    Ann N Y Acad Sci; 2006 Oct; 1079():147-52. PubMed ID: 17130546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
    Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
    Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of poloxamer 407 on the functional properties of HDL in mice.
    Yasuda T; Johnston TP; Shinohara M; Inoue M; Ishida T
    J Pharm Pharmacol; 2012 May; 64(5):677-87. PubMed ID: 22471363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular phospholipases in atherosclerosis.
    Karabina SA; Gora S; Atout R; Ninio E
    Biochimie; 2010 Jun; 92(6):594-600. PubMed ID: 20153800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
    Zhang B; Fan P; Shimoji E; Itabe H; Miura S; Uehara Y; Matsunaga A; Saku K
    Atherosclerosis; 2006 Jun; 186(2):291-301. PubMed ID: 16154574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
    Karantonis HC; Antonopoulou S; Perrea DN; Sokolis DP; Theocharis SE; Kavantzas N; Iliopoulos DG; Demopoulos CA
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):174-85. PubMed ID: 16580585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.